Skip to content
  • Sunday, 26 July 2026
  • 1:43 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Here’s What Everyone Gets Wrong About Agentic AI
Data Science & Bioinformatics

Here’s What Everyone Gets Wrong About Agentic AI

Evan Lee Salim Jun 25, 2026 0

In July 2025, a seemingly innocuous instruction given to an AI coding agent by developer Jason Lemkin precipitated a "catastrophic…

Read More
Laboratory Automation & Robotics

The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis

Lana Keisha Mar 30, 2026 0

A paradigm shift in the understanding of GLP-1 receptor agonists, widely recognized as transformative agents in the battle against obesity…

Read More
Laboratory Automation & Robotics

The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis

Lana Keisha Mar 23, 2026 0

A groundbreaking shift in the understanding of weight management outcomes following the cessation of GLP-1 agonist medications is emerging, challenging…

Read More
Stanford Medicine Researchers Discover Glucose Functions as a Master Regulator of Tissue Differentiation Beyond its Role as an Energy SourceThe biotech bi-weekly: a disease modeling research grant and an accelerator program for data-driven health start-upsTop 7 Docker Compose Templates Every Developer Should UseScience News Empowers Public Understanding of Science, Medicine, and Technology
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ